Your browser doesn't support javascript.
loading
Maximizing the Impact of Physiologically Based Oral Absorption Modeling and Simulation.
Chung, John I; Kelly, Ron C; Wahlstrom, Jan; Wu, Benjamin; Wu, Tian; Alvarez-Nunez, Fernando.
Afiliação
  • Chung JI; Amgen Inc., Drug Product Technologies, Thousand Oaks, California 91320. Electronic address: jochung@amgen.com.
  • Kelly RC; Amgen Inc., Drug Product Technologies, Thousand Oaks, California 91320.
  • Wahlstrom J; Amgen Inc., Pharmacokinetics and Drug Metabolism, Thousand Oaks, California 91320.
  • Wu B; Amgen Inc., Medical Sciences, Thousand Oaks, California 91320.
  • Wu T; Amgen Inc., Drug Product Technologies, Thousand Oaks, California 91320.
  • Alvarez-Nunez F; Amgen Inc., Drug Product Technologies, Thousand Oaks, California 91320.
J Pharm Sci ; 106(3): 734-737, 2017 03.
Article em En | MEDLINE | ID: mdl-27915208
ABSTRACT
The challenge of bringing innovative medicines to patients in combination with intense competition within the pharmaceutical industry has induced companies to develop quality medicines more efficiently and cost-effectively. State-of-the-art approaches to advance drug development have never been so urgent. One such approach that has been gaining traction within the industry is the application of modeling and simulation. In this commentary, the benefits of physiologically based oral absorption modeling and simulation in drug development are highlighted and suggestions for maximizing its impact are provided.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Simulação por Computador / Preparações Farmacêuticas / Absorção Gastrointestinal / Modelos Biológicos Limite: Humans Idioma: En Revista: J Pharm Sci Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Simulação por Computador / Preparações Farmacêuticas / Absorção Gastrointestinal / Modelos Biológicos Limite: Humans Idioma: En Revista: J Pharm Sci Ano de publicação: 2017 Tipo de documento: Article